Published projects

Search by year

Reset filters

Title State Date

Kabazitaxel (Cabazitaxel EVER Pharma)

Published

16.01.202599.99.9999

Detail

Information

Illness:

Karcinóm prostaty

Intervention:

Kabazitaxel

Required indication:

Kabazitaxel na liečbu dospelých mužov s metastatickým kastračne rezistentným karcinómom prostaty, u ktorých došlo k progresii ochorenia počas alebo po liečbe docetaxelom

Start of assessment:

1.8.2024

Deadline for submission of input from experts and patients:

25.10.2024

Proceedings ID on the categorization portal:

29463, 29464, 29465

Project type

Accelerated Technology Assessment

Technology type

Medicine 

Documents Kabazitaxel – hodnotenie – ZHL096 PDF | 1 MB | 16.01.2025

Siltuximab (Sylvant)

Published

10.01.202599.99.9999

Detail

Information

Illness:

Idiopatická multicentrická Castlemanova choroba

Intervention:

Siltuximab

Required indication:

Siltiximab na liečbu dospelých pacientov s idiopatickou multicentrickou Castlemanovou chorobou

Start of assessment:

1.8.2024

Deadline for submission of input from experts and patients:

11.10.2024

Proceedings ID on the categorization portal:

31222, 31223

Project type

Accelerated Technology Assessment

Technology type

Medicine 

Documents Siltuximab – hodnotenie – ZHL101 PDF | 1 MB | 10.01.2025

Berotralstat (Orladeyo)

Published

10.01.202599.99.9999

Detail

Information

Illness:

Hereditárny angioedém

Intervention:

Berotralstat

Required indication:

Berotralstat na rutinnú liečbu pacientov od 12 rokov s hereditárnym angioedémom I. a II. typu

Start of assessment:

1.8.2024

Deadline for submission of input from experts and patients:

6.12.2024

Proceedings ID on the categorization portal:

33907

Project type

Accelerated Technology Assessment

Technology type

Medicine 

Documents Berotralstat – hodnotenie ZHL110 PDF | 1 MB | 10.01.2025

Vozoritid (Voxzogo)

Published

03.01.202599.99.9999

Detail

Information

Illness:

Achondroplázia

Intervention:

Vozoritid

Required indication:

Vozoritid na liečbu pacientov s achondropláziou vo veku 4 mesiacov a starších, ktorých epifýzy nie sú uzavreté

Start of assessment:

31.7.2024

Deadline for submission of input from experts and patients:

5.9.2024

Proceedings ID on the categorization portal:

34759, 34760, 34761

Project type

Standard Technology Assessment

Technology type

Medicine 

Documents Vozoritid – hodnotenie – L84 PDF | 3 MB | 03.01.2025 Vozoritid – projektový protokol – L84 PDF | 245 KB | 21.08.2024

Mavakamten (Camzyos)

Published

20.12.202499.99.9999

Detail

Information

Illness:

symptomatická obštrukčná hypertrofická kardiomyopatia

Intervention:

Mavakamten

Required indication:

Mavakamten na liečbu dospelých pacientov so symptomatickou (NYHA II a III) obštrukčnou hypertrofickou kardiomyopatiou

Start of assessment:

21.08.2024

Deadline for submission of input from experts and patients:

4.10.2024

Proceedings ID on the categorization portal:

34992, 34993, 34994, 34995

Project type

Standard Technology Assessment

Technology type

Medicine 

Documents Mavakamten – projektový protokol – L136 PDF | 275 KB | 20.09.2024 Camzyos – hodnotenie L136 PDF | 3 MB | 20.12.2024

Gél na rany HYIODINE

Published

20.12.202499.99.9999

Detail

Information

Subgroup:

A8.3.4 Gél s aktívnym jódom a kyselinou hyalurónovou (nová podskupina)

Intervention:

Gél na krytie, čistenie a hydratáciu rán HYIODINE – sterilný, antiadhezívny, čistiaci, hydratačný; 50 g

Required indication:

Hlboké preležaniny, diabetické defekty, vredy predkolenia, popáleniny, rozpadnuté operačné rany, ťažko sa hojace rany a rozsiahle odreniny.

Start of assessment:

20.8.2024

Deadline for submission of input from experts and patients:

13.11.2024

Proceedings ID on the categorization portal:

14401

Project type

Accelerated Technology Assessment

Technology type

Medical aid

Documents HYIODINE – hodnotenie – ZHZP4 PDF | 1 MB | 20.12.2024

Glykopyrónium (Sialanar)

Published

20.12.202499.99.9999

Detail

Information

Illness:

Sialorea

Intervention:

Glykopyrónium

Required indication:

Glykopyrónium (Sialanar) na liečbu detských pacientov od 3 rokov so závažnou sialoreou (chronické patologické slinenie) a chronickými neurologickými poruchami

Start of assessment:

1.8.2024

Deadline for submission of input from experts and patients:

20.9.2024

Proceedings ID on the categorization portal:

29643

Project type

Accelerated Technology Assessment

Technology type

Medicine 

Documents Sialanar – hodnotenie – ZHL95 PDF | 1 MB | 20.12.2024

Tofacitinib (Xeljanz)

Published

19.12.202499.99.9999

Detail

Information

Illness:

Ankylozujúca spondylitída

Intervention:

Tofacitinib

Required indication:

Liečivo tofacitinib (Xeljanz) na liečbu dospelých pacientov s aktívnou ankylozujúcou spondylitídou, ktorí nedostatočne odpovedali na konvenčnú liečbu a u ktorých liečba liekom zo skupiny inhibítorov TNF alfa nie je vhodná alebo nebola dostatočne účinná

Start of assessment:

1.8.2024

Deadline for submission of input from experts and patients:

17.9.2024

Proceedings ID on the categorization portal:

29460

Project type

Accelerated Technology Assessment

Technology type

Medicine 

Documents Xeljanz – hodnotenie – ZHL90 PDF | 1 MB | 19.12.2024